论文部分内容阅读
最新的医改征求意见稿所提方案面世后,在社会上引起了很大反响。许多人都在关注怎样解决看病贵、看病难,怎样使患者得到最好的救治,怎样提高医生待遇等问题。但是作为医改环节利益链条中重要组成部分之一的药企是否有人关注?“整整1万多字的医改方案中,与医药产业相关的只有700多字。”一位医药行业协会会长在近日召开的全国医药行业协会会长和秘书长联席会上对此提出质疑。
The latest proposal for medical reform draft was published in the community, has aroused great repercussions. Many people are concerned about how to solve the problems of expensive medical treatment, difficult medical treatment, how to get the best treatment for patients and how to improve medical treatment. However, whether the pharmaceutical companies, as one of the most important components in the interest chain of medical reform, are concerned about the medical reform of more than 10,000 words, only about 700 words are related to the pharmaceutical industry. “” President of the Pharmaceutical Industry Association In the recently held by the National Association of Pharmaceutical Industry and the Secretary-General joint meeting questioned this.